New ALT Biomarker Enhances Prognostic Accuracy in Pancreatic Neuroendocrine Tumors
May 28, 2025
Pancreatic neuroendocrine tumors (PanNETs) can have a variety of behaviors. Some stay slow-growing for years,
$39.8M
Million in NET research funding
50
Active Research
Projects
17
Countries with ongoing studies
Pancreatic neuroendocrine tumors (PanNETs) can have a variety of behaviors. Some stay slow-growing for years,
In a breakthrough for those with advanced pheochromocytoma and paraganglioma (Pheo/Para), the U.S. Food and
In a recent interview with CancerNetwork®, Dr. Anna Greene, Director of Research at the Neuroendocrine
You can support a brighter future. Make a gift. Host an event. Or volunteer to help us advance our understanding of neuroendocrine tumors.
Learn about neuroendocrine tumor tests, treatments, and research. Find out about educational and inspirational events in the NET community.
NETRF hosts free patient and caregiver neuroendocrine tumor conferences to educate and empower individuals to be part of their care planning and live their best life.